Jakarta (ANTARA) - The communicable disease trend in Indonesia has started to shift and return to the condition before the pandemic struck, Minister of Health Budi Gunadi Sadikin told ANTARA after an MoU-inking event here Monday.

The trend in communicable diseases getting started with COVID-19 infections being largely reported has shifted to several small outbreaks of diseases, such as tuberculosis, HIV, and malaria, he explained.

This is due to a stagnation of vaccination rates in several regions. He deemed that this stagnation also caused the emergence of several new diseases among members of the public.

Thus, by collaborating with stakeholders, cooperation can be strengthened, so that Indonesia can independently produce vaccines for various types of communicable diseases.

To this end, the Ministry of Health has extended cooperation through the signing of a memorandum of understanding (MoU) with PT AstraZeneca.

Sadikin told the company that the government is keen that all vaccines for communicable diseases be developed in Indonesia.

To this end, the government seeks to have the company's technology to produce vaccines be brought here, given that it is a major global vaccine company.

He also urged the company and other stakeholders to distribute their corporate social responsibility (CSR) fund to preventive and promotional programs that support broad health education to the public.

On the occasion, Sadikin also noted that the finding of new suspected Atypical Progressive Acute Kidney Injury (GGAPA) cases in children in West Java possibly indicated the presence of measles.

It cannot yet be confirmed whether the patients are experiencing poisoning due to Ethylene Glycol (EG) and Diethylene Glycol (DEG) compounds present in syrup medicines.

As a result, the medical staff at Cipto Mangunkusumo Hospital, here, still conducts further examination.

Related news: Be wary of communicable diseases during seasonal transition: official
Related news: Govt using COVID strategy to tackle non-communicable diseases


Translator: Hreeloita D S, Fadhli Ruhman
Editor: Rahmad Nasution
Copyright © ANTARA 2023